Meta H.M. Diekstra

CYP3A5 and ABCB1 Polymorphisms as Predictors for Sunitinib Outcome in Metastatic Renal Cell Carcinoma

Meta H.M. Diekstra, Jesse J. Swen, Epie Boven et al. · European Urology · 2015 · 90 citations

Medicine, Oncology, Pharmacology +16

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

Meta H.M. Diekstra, Heinz‐Josef Klümpen, Martijn P. Lolkema et al. · Clinical Pharmacology & Therapeutics · 2014 · 76 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +17

Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma

Meta H.M. Diekstra, A Belaústegui, Jesse J. Swen et al. · The Pharmacogenomics Journal · 2016 · 25 citations · Full text

Medicine, Oncology, Pharmacology +16

Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

Meta H.M. Diekstra, Xiaoyan Liu, Jesse J. Swen et al. · European Journal of Clinical Pharmacology · 2015 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer—GEnetic- and tumor-related biomarkers for response and toxicity

Loes F.M. van der Zanden, Sita H. Vermeulen, Arna Óskarsdóttir et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17